MAPK3 and breast cancer: It has been reported that extracellular signal-regulated kinase (ERK) signalling is a crucial pathway for the regulation of cell proliferation, differentiation, survival and cell motility in both normal and cancer cells [46–48], and the activation of ERK1/2 stimulates the expression of VEGFa in breast cancer cells [49].